Daniel F Hoft
Overview
Explore the profile of Daniel F Hoft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
3738
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu Y, Meza K, Colbert C, Hoft D, Jaunarajs A, Blazevic A, et al.
Vaccines (Basel)
. 2025 Jan;
13(1).
PMID: 39852806
Background: Available assays to measure pox virus neutralizing antibody titers are laborious and take up to 5 days. In addition, assays to measure T cell responses require the use of...
2.
Wei J, Ning H, Ramos-Espinosa O, Eickhoff C, Hou R, Wang Q, et al.
FASEB Bioadv
. 2024 Aug;
6(8):249-262.
PMID: 39114448
Immune evasion of (Mtb) facilitates intracellular bacterial growth. The mechanisms of immune evasion, however, are still not fully understood. In this study, we reveal that tristetraprolin (TTP), one of the...
3.
Hill-Batorski L, Weiner J, Ackerman M, Hatta Y, Hoft D, Herber R, et al.
J Infect Dis
. 2024 Jul;
231(1):214-218.
PMID: 39012796
No abstract available.
4.
Silver R, Xia M, Storer C, Jarvela J, Moyer M, Blazevic A, et al.
Nat Commun
. 2023 Dec;
14(1):8507.
PMID: 38129388
Tuberculosis remains an international health threat partly because of limited protection from pulmonary tuberculosis provided by standard intradermal vaccination with Bacillus of Calmette and Guérin (BCG); this may reflect the...
5.
Blazevic A, Edwards R, Xia M, Eickhoff C, Hamzabegovic F, Meza K, et al.
J Infect Dis
. 2023 Nov;
229(5):1498-1508.
PMID: 38019956
Background: A controlled human infection model for assessing tuberculosis (TB) immunity can accelerate new vaccine development. Methods: In this phase 1 dose escalation trial, 92 healthy adults received a single...
6.
Eickhoff C, Meza K, Terry F, Colbert C, Blazevic A, Gutierrez A, et al.
Front Immunol
. 2023 Sep;
14:1247876.
PMID: 37705976
Zika virus (ZIKV) is a flavivirus primarily transmitted by species mosquitoes, first discovered in Africa in 1947, that disseminated through Southeast Asia and the Pacific Islands in the 2000s. The...
7.
Rasi V, Phelps K, Paulson K, Eickhoff C, Chinnaraj M, Pozzi N, et al.
J Infect Dis
. 2023 Sep;
229(3):876-887.
PMID: 37671668
Mycobacterium tuberculosis (Mtb)-specific γ9δ2 T cells secrete granzyme A (GzmA) protective against intracellular Mtb growth. However, GzmA-enzymatic activity is unnecessary for pathogen inhibition, and the mechanisms of GzmA-mediated protection remain...
8.
El Sahly H, Yildirim I, Frey S, Winokur P, Jackson L, Bernstein D, et al.
J Infect Dis
. 2023 Jul;
229(2):327-340.
PMID: 37466221
Background: Influenza A (H7N9) has caused multiple disease waves with evidence of strain diversification. Optimal influenza A (H7N9) prime-boost vaccine strategies are unknown. Methods: We recruited participants who had received...
9.
Salas J, Morley J, Hoft D, Scherrer J
Prev Med Rep
. 2023 Jul;
35:102302.
PMID: 37441187
Influenza, tetanus, diphtheria, and herpes zoster (HZ) vaccination received within 10 years of the COVID-19 pandemic have been associated with less severe COVID-19 infection. We expanded on this evidence to...
10.
Xia M, Blazevic A, Fiore-Gartland A, Hoft D
Front Immunol
. 2023 Apr;
14:1100490.
PMID: 37056780
Introduction: Tuberculosis (TB) caused by (Mtb) infection is a serious threat to human health. Vaccination with BCG prevents the development of the most severe forms of TB disease in infants...